References
- Breast cancer facts and figures, 2001. Atlanta: American Cancer Society, 2001
- Garfinkel L, Boring CC, Heath CW Jr. Changing trends: an overview of breast cancer incidence and mortality. Cancer 1994: 74(1 Suppl): 222–7
- Ernster VL, Barclay J, Kerlikowske K, et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275(12): 913–8
- Madigan MP, Ziegler RG, Benichou J, et al. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995; 87(22): 1681–5
- Greene MH. Genetics of breast cancer. Mayo Clin Proc 1997; 72(1): 54–65
- Hoskins KF, Stopfer JE, Calzone KA, et al. Assessment and counseling for women with a family history of breast cancer: a guide for clinicians. JAMA 1995; 273(7): 577–85
- Pinsky LE, Culver JB, Hull J, et al. Why should primary care physicians know about breast cancer genetics? West J Med 2001; 175(3): 168–73
- ACOG committee opinion. Breast-ovarian cancer screening. No. 239, Aug 2000. American College of Obstetricians and Gynecologists. Committee on genetics. Int J Gynaecol Obstet 2001; 75(3): 339–40
- Keating JE, Cleary PD, Rossi AS, et al. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999; 130(7): 545–53
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288(3): 321–33
- Baxter N. Preventive health care, 2001 update: Should women be routinely taught breast self-examination to screen for breast cancer? Can Med Assoc J 2001; 164(13): 1837–46
- Screening for breast cancer: recommendations and rationale. Rockville, Md: Agency for Healthcare Research and Quality, 2002
- Blamey RW, Wilson AR, Patnick J. ABC of breast diseases: screening for breast cancer. BMJ 2000; 321(7262): 689–93
- Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography: a meta-analysis. JAMA 1995; 273(2): 149–54
- Ringash J. Preventive health care, 2001 update: screening mammography among women aged 40–49 years at average risk of breast cancer. Can Med Assoc J 2001; 164(4): 469–76
- Hendrick RE, Smith RA, Rutledge JH III, et al. Benefit of screening mammography in women aged 40–49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997; (22): 87–92
- Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998; 338(16): 1089–96
- Black WC, Nease RF Jr, Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995; 87(10): 720–31
- Gail MH, Brinton LA, Byar DP. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81(24): 1879–86
- Costantino JP, Gail MH, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999; 91(18): 1541–8
- Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med 2000; 342(8): 564–71
- Fisher B, Costantino JP, Wickerham DL. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90(18): 1371–88